Country
stringclasses
20 values
Year
int64
2k
2.02k
Disease Name
stringclasses
20 values
Disease Category
stringclasses
11 values
Prevalence Rate (%)
float64
0.1
20
Incidence Rate (%)
float64
0.1
15
Mortality Rate (%)
float64
0.1
10
Age Group
stringclasses
4 values
Gender
stringclasses
3 values
Population Affected
int64
1k
1,000k
Healthcare Access (%)
float64
50
100
Doctors per 1000
float64
0.5
5
Hospital Beds per 1000
float64
0.5
10
Treatment Type
stringclasses
4 values
Average Treatment Cost (USD)
int64
100
50k
Availability of Vaccines/Treatment
stringclasses
2 values
Recovery Rate (%)
float64
50
99
DALYs
int64
1
5k
Improvement in 5 Years (%)
float64
0
10
Per Capita Income (USD)
int64
502
100k
Education Index
float64
0.4
0.9
Urbanization Rate (%)
float64
20
90
Saudi Arabia
2,002
Hypertension
Autoimmune
18.06
3.95
1.25
36-60
Male
905,138
90.84
1.29
5.05
Vaccination
10,090
No
51.28
306
9.37
21,361
0.48
60.06
USA
2,019
Parkinson's Disease
Cardiovascular
10.36
5.64
1.54
36-60
Other
520,943
89.88
3.76
5.64
Vaccination
5,810
Yes
58.77
1,499
9.1
37,981
0.89
20.46
UK
2,018
Polio
Infectious
1.95
3.78
2.81
0-18
Male
827,125
81.86
1.68
9.66
Therapy
28,784
No
96.96
2,509
4.03
35,630
0.71
26.36
China
2,005
Polio
Cardiovascular
14.82
6.72
4.64
0-18
Other
57,799
52.96
4.37
1.9
Therapy
40,429
No
60.29
1,227
9.71
53,091
0.88
40.62
Brazil
2,013
Influenza
Infectious
7.13
13.81
7.19
0-18
Other
493,680
61
3.39
5.28
Medication
46,186
Yes
66.91
1,640
9.03
6,335
0.48
24.36
Brazil
2,022
Cancer
Bacterial
8.95
4.13
0.24
19-35
Male
303,517
59.23
4.75
3.23
Medication
18,869
Yes
78.06
1,286
7.52
24,972
0.82
58.71
Russia
2,002
Hepatitis
Bacterial
14.31
6.86
9.71
0-18
Male
874,491
59.76
1.79
3.49
Vaccination
47,260
Yes
87.04
154
4.96
65,783
0.69
67.11
Canada
2,011
Ebola
Metabolic
1.18
13.12
1.65
19-35
Male
556,700
74.68
2.23
2.75
Medication
29,154
Yes
79.12
502
6.49
93,201
0.75
53.05
Turkey
2,013
Cholera
Metabolic
14.94
7.76
4.11
36-60
Other
597,321
75.54
0.64
2.61
Therapy
12,347
Yes
78.42
3,900
1.96
83,096
0.73
48.96
Saudi Arabia
2,006
Cholera
Bacterial
9.99
12.81
8.48
0-18
Other
862,608
56.29
3.53
8.1
Medication
43,227
Yes
96.76
2,573
2.1
37,124
0.44
52.17
Russia
2,002
COVID-19
Respiratory
13.02
14.89
3.98
36-60
Male
482,042
77.59
0.6
2.75
Surgery
29,381
Yes
97.08
3,993
2.84
65,486
0.56
52.69
UK
2,007
Dengue
Bacterial
17.73
2.49
8.39
0-18
Male
195,702
58.78
4.11
1.68
Vaccination
30,445
No
93.03
4,554
3.5
88,416
0.54
27.53
Mexico
2,004
Tuberculosis
Viral
6.13
4.66
6.1
36-60
Female
80,676
60.89
4.97
3.1
Medication
11,898
Yes
63.14
617
6.91
42,961
0.61
64.17
Canada
2,023
Asthma
Cardiovascular
16.73
8.97
7.67
0-18
Female
718,094
87.45
2.12
5.36
Medication
29,829
Yes
64.75
4,568
9.96
72,405
0.66
84.13
Japan
2,011
Hepatitis
Genetic
3.75
4.12
0.5
0-18
Male
505,235
75.07
2.86
7.6
Surgery
36,055
Yes
52.87
534
9.6
4,233
0.57
35.49
Argentina
2,001
Ebola
Neurological
10.65
11
2.62
61+
Male
408,148
58.68
2.38
1.71
Vaccination
6,387
Yes
68.18
855
8.47
74,843
0.55
84.59
UK
2,022
Parkinson's Disease
Autoimmune
19.91
8.03
9.6
36-60
Male
784,892
72.46
2.74
2.43
Vaccination
40,429
Yes
94.85
4,928
9.3
9,830
0.45
50.6
China
2,013
Parkinson's Disease
Bacterial
17.23
7.14
8.85
36-60
Male
968,496
60
4.88
7.4
Medication
41,737
Yes
77.99
3,365
2.44
14,301
0.88
39.78
Nigeria
2,001
Measles
Respiratory
2.65
1.96
4.88
61+
Male
595,413
69.65
3.18
7.92
Vaccination
5,223
No
98.82
2,733
4.4
9,155
0.46
40.03
Germany
2,003
Measles
Autoimmune
16.59
4.79
2.61
61+
Female
117,862
99.91
4.74
3.66
Therapy
8,156
Yes
93.93
4,502
7.34
48,162
0.84
37.59
Japan
2,011
Polio
Metabolic
6.31
8.75
6.67
0-18
Male
333,244
68.92
2.35
1.42
Therapy
13,098
No
67.48
3,772
7.92
87,077
0.47
77.46
Saudi Arabia
2,023
Malaria
Parasitic
5.75
14.27
5.05
0-18
Male
805,599
51.51
0.97
5.73
Therapy
36,521
No
71.75
3,098
9.22
58,692
0.4
37.24
UK
2,020
Rabies
Chronic
7.01
11.18
4.61
36-60
Other
116,279
74.66
1.93
9.82
Surgery
7,881
No
54.38
1,906
9.04
72,334
0.45
64.75
UK
2,019
Ebola
Cardiovascular
2.87
6.11
6.61
36-60
Female
79,601
60.79
1.22
7.93
Medication
34,861
Yes
75.14
1,720
8.53
17,568
0.73
63.29
France
2,015
Zika
Cardiovascular
12.55
7.66
3.68
19-35
Female
408,058
62.95
2.64
8.86
Therapy
25,437
No
53.4
3,748
4.04
53,720
0.48
41.48
China
2,016
Dengue
Parasitic
7.37
12.28
1.75
36-60
Male
368,664
52.17
3.94
3.81
Therapy
27,591
No
84.44
3,898
7.34
88,045
0.74
39.83
Indonesia
2,011
Diabetes
Viral
14.12
0.6
0.35
36-60
Female
197,846
52.7
4.12
9.26
Therapy
31,075
No
92.35
4,582
6.09
98,089
0.8
34.19
Australia
2,018
Dengue
Autoimmune
10.82
4.64
6.29
0-18
Other
462,151
80.56
1.48
4.83
Vaccination
40,220
No
68.71
803
9.91
4,420
0.51
49.36
Turkey
2,009
Ebola
Autoimmune
8.94
12.24
8.43
61+
Female
244,014
55.26
2.93
1.07
Vaccination
13,217
No
77.27
1,665
6.36
19,217
0.47
23.33
Argentina
2,017
Hypertension
Cardiovascular
9.76
2.98
7.9
0-18
Female
102,201
71.89
4.23
1.91
Surgery
27,376
Yes
74.35
3,843
9.56
97,615
0.42
86.84
Argentina
2,008
Tuberculosis
Respiratory
8.23
9.33
3.52
19-35
Male
998,313
62.42
3.98
4.54
Therapy
3,561
Yes
63.94
4,827
1.56
56,434
0.54
40.92
Australia
2,012
Ebola
Neurological
6.11
13.52
4.83
0-18
Other
674,468
53
1.01
9.01
Surgery
21,210
No
53.68
2,859
4.2
81,925
0.4
23
Argentina
2,018
Asthma
Genetic
1.74
4.3
3.9
0-18
Male
875,980
93.82
3.22
5.3
Surgery
5,236
Yes
55.27
1,235
5.03
5,316
0.55
55.75
Saudi Arabia
2,014
Rabies
Neurological
7.06
1.04
3.75
61+
Male
509,395
55.37
0.61
2.9
Therapy
39,000
Yes
54.54
2,745
7.75
31,080
0.57
85.99
China
2,019
Asthma
Metabolic
6.19
10.04
1.24
19-35
Female
693,766
82.03
3.98
9.98
Vaccination
23,722
No
51.51
4,979
6.38
84,260
0.8
46.05
Indonesia
2,013
Rabies
Infectious
8.71
11.15
6.82
0-18
Female
653,700
67.61
1.36
8.91
Medication
35,326
No
80.73
1,829
7.6
80,760
0.55
41.92
Nigeria
2,024
Diabetes
Bacterial
16.13
12.82
5
61+
Male
842,486
51.52
1.65
4.99
Medication
12,674
No
59.1
4,610
1.7
37,570
0.48
61.67
Germany
2,020
HIV/AIDS
Autoimmune
2.01
12.76
3.68
36-60
Female
414,682
77.51
3.04
3.48
Therapy
39,102
Yes
59.44
1,926
4.12
61,683
0.83
62.36
Germany
2,013
Alzheimer's Disease
Bacterial
11.84
10.35
0.3
36-60
Female
538,243
87.69
3.45
0.82
Vaccination
39,923
No
62.68
3,639
1.55
79,667
0.54
67.38
UK
2,020
HIV/AIDS
Parasitic
19.73
5.72
1.48
61+
Female
680,979
60.34
2.56
4.25
Vaccination
18,992
Yes
65.49
2,693
5.94
92,200
0.87
86.44
Russia
2,008
Diabetes
Respiratory
3.63
10.1
1.94
0-18
Male
333,792
80.07
3.93
4.17
Medication
10,305
No
59.27
1,510
6.31
47,842
0.52
43.76
Saudi Arabia
2,005
Tuberculosis
Autoimmune
5.74
3.29
0.46
61+
Other
635,283
93.73
1.01
3.34
Vaccination
43,112
Yes
94.64
3,322
9.55
76,878
0.54
44.38
India
2,018
Alzheimer's Disease
Chronic
16.78
3.29
4.01
19-35
Other
628,400
69.27
2.78
3.77
Medication
11,430
No
96.15
3,386
7.55
62,078
0.56
24.71
Brazil
2,022
HIV/AIDS
Viral
6.26
0.31
5.66
36-60
Male
505,634
64.86
4.85
1.4
Therapy
49,555
Yes
93.78
2,439
2.82
62,342
0.41
58.05
Turkey
2,008
Alzheimer's Disease
Bacterial
3.99
2.79
0.55
19-35
Male
399,339
81.58
3.4
4.45
Medication
34,345
Yes
96.24
133
8.47
76,521
0.72
45.01
UK
2,024
HIV/AIDS
Cardiovascular
14.96
4.76
2.49
19-35
Male
517,524
93.99
1.7
4.58
Medication
15,082
Yes
61.76
1,938
0.59
31,025
0.89
70.56
Italy
2,008
Leprosy
Neurological
18.23
11.27
2.98
19-35
Female
446,302
92.41
1.98
2
Vaccination
36,869
Yes
93.63
2,648
6.61
56,432
0.85
71.8
South Africa
2,020
Parkinson's Disease
Metabolic
10.25
13.73
1.29
0-18
Other
93,749
61.03
4.29
2.69
Therapy
44,091
No
79.14
60
5.93
97,861
0.66
52.2
Japan
2,012
Measles
Metabolic
7.59
7.26
1.46
61+
Male
328,970
52.37
3.61
2.59
Vaccination
32,447
Yes
64.1
3,384
5.91
99,095
0.46
42.03
Saudi Arabia
2,000
Cholera
Autoimmune
1.6
5.25
4
0-18
Other
902,073
64.69
0.78
2.61
Surgery
6,268
No
71.9
3,272
2.29
73,902
0.84
86.47
Argentina
2,022
Zika
Bacterial
4.74
11.58
0.22
36-60
Female
607,792
74.47
4.62
9.22
Surgery
32,844
Yes
53.74
2,133
3.26
5,913
0.76
80.1
Russia
2,013
Tuberculosis
Cardiovascular
18.17
12.9
5.84
19-35
Female
506,444
98.12
3.81
9.87
Medication
43,654
No
58.99
4,554
5.06
6,992
0.49
47.66
South Korea
2,000
Ebola
Parasitic
5.06
14.59
4.82
19-35
Female
274,585
57.31
0.91
7.22
Surgery
39,900
Yes
62.83
4,938
7.27
33,803
0.75
60.48
India
2,015
Zika
Bacterial
18.4
14.82
8.09
36-60
Male
421,037
59.38
3.32
6.59
Therapy
14,455
Yes
80.39
3,347
2.39
1,226
0.68
59.98
Nigeria
2,022
Polio
Infectious
18.29
7.22
3.45
0-18
Male
933,548
78.68
3.6
2.04
Surgery
36,229
No
76.05
1,315
4.53
30,095
0.5
58.37
Saudi Arabia
2,007
Cancer
Autoimmune
2.88
11.6
7.64
61+
Female
642,241
53.58
2.88
9.16
Surgery
37,392
Yes
96.99
280
6.45
50,706
0.42
63.81
South Korea
2,023
COVID-19
Bacterial
19.55
3.32
9.63
61+
Female
156,444
77.02
4.05
7.13
Therapy
45,023
No
94.37
2,474
9.35
75,214
0.54
28.37
Germany
2,001
Zika
Viral
6.29
0.66
8.19
61+
Female
531,007
57.31
2.66
1.88
Vaccination
34,739
No
52.65
4,978
2.29
1,111
0.66
80.55
Argentina
2,011
Ebola
Bacterial
19.42
1.28
4.63
61+
Other
812,951
77.91
4.26
0.52
Surgery
24,514
No
97.27
3,257
8.45
98,681
0.44
79.1
South Africa
2,011
Measles
Neurological
19.41
13.13
2.53
0-18
Other
286,167
69.14
2.93
8.58
Surgery
13,061
No
60.44
4,420
4.6
84,911
0.52
56.95
India
2,001
Cancer
Genetic
7.66
7.85
5.11
19-35
Male
907,430
55.19
3.5
8.6
Medication
2,977
No
77.53
3,002
9.15
69,278
0.61
63.33
Japan
2,010
Rabies
Bacterial
18.83
1.83
1.89
0-18
Male
41,909
80.05
4.17
3.56
Vaccination
29,602
Yes
61.69
733
5.74
9,059
0.41
74.2
Turkey
2,005
Hepatitis
Viral
10.31
6.85
4.97
19-35
Female
785,885
71.89
4.46
7.78
Surgery
8,126
No
51.35
3,297
9.28
13,373
0.58
69.91
Russia
2,014
COVID-19
Infectious
11.11
6.5
4.72
61+
Male
143,452
54.16
4.95
2.96
Vaccination
35,363
No
77.16
703
5.51
35,473
0.74
88.41
Turkey
2,000
Hypertension
Infectious
11.11
11.28
3.93
0-18
Other
562,280
56.39
4.96
4.61
Vaccination
43,899
Yes
56.27
980
7.02
18,703
0.85
26.87
Australia
2,009
Leprosy
Chronic
17.2
9.33
0.93
19-35
Male
382,033
71.15
3.89
4.66
Therapy
7,408
No
71.96
3,840
8.03
42,779
0.65
59.7
UK
2,010
Alzheimer's Disease
Viral
8.25
12.58
3.71
19-35
Other
675,496
74.48
1.56
3.02
Vaccination
22,844
No
57.49
4,385
2.23
95,199
0.75
83.45
South Korea
2,022
Diabetes
Autoimmune
11.55
9.25
4.31
0-18
Male
407,221
97.45
3.35
5.15
Surgery
12,089
No
88.54
354
3.56
28,911
0.85
65.59
India
2,017
Asthma
Viral
13.88
6.23
5.16
36-60
Other
265,312
99.68
3.2
8.71
Medication
30,939
Yes
54.42
4,388
8.49
28,892
0.59
60.53
Turkey
2,023
Parkinson's Disease
Infectious
0.55
5.18
7.77
0-18
Female
235,388
82.45
2.27
0.74
Therapy
13,160
No
98.94
1,745
7.32
29,618
0.56
49.8
Russia
2,019
Zika
Bacterial
1.03
8.26
6.17
61+
Other
793,789
85.27
1.13
4.92
Medication
8,906
Yes
66.71
4,984
4.9
94,811
0.66
52.55
UK
2,000
Cancer
Infectious
15.69
14.45
4.75
61+
Female
906,787
58.65
2.31
3.22
Medication
20,051
Yes
84.61
3,602
1.34
57,313
0.64
78.48
USA
2,019
Ebola
Respiratory
7.27
7.11
9.48
0-18
Other
696,180
87.68
2.42
4.02
Therapy
28,926
No
89.78
3,683
5.87
40,663
0.74
43.51
Italy
2,019
Dengue
Cardiovascular
5.97
4.65
5.35
0-18
Male
101,330
90.12
0.74
1.81
Therapy
34,838
No
70.68
467
2.35
69,819
0.88
57.41
Mexico
2,008
Measles
Viral
14.43
14.96
6.21
61+
Male
355,421
62.45
3.02
8.87
Vaccination
46,377
No
83.16
503
7.64
63,064
0.56
27.72
Canada
2,014
Influenza
Autoimmune
8.22
12.23
9.53
0-18
Female
423,690
80.91
1.15
5.19
Therapy
44,102
Yes
86.99
1,016
5.16
7,273
0.56
84.29
South Africa
2,016
Hypertension
Cardiovascular
11.52
2.94
6.18
19-35
Male
266,560
59.58
3.51
6.6
Therapy
16,039
Yes
74.9
4,431
3.89
2,619
0.88
29.51
Indonesia
2,013
Cholera
Neurological
8.56
8.17
4
61+
Female
718,269
80.55
4.49
6.59
Medication
19,963
No
94.26
543
1.92
95,041
0.86
80.8
USA
2,016
Hepatitis
Neurological
14.8
14.03
7.85
0-18
Female
157,140
76.7
4.81
8.98
Surgery
22,683
No
72.08
4,072
3.32
81,434
0.7
79.71
France
2,023
Cholera
Cardiovascular
7.06
5.36
0.85
61+
Male
373,931
60.81
2.11
1.83
Surgery
7,928
No
66.94
3,443
7.92
68,110
0.67
26.63
Russia
2,013
HIV/AIDS
Autoimmune
4.33
7.71
7.05
61+
Other
311,127
96.16
1.58
9.7
Medication
9,837
Yes
69.41
4,144
3.07
48,487
0.72
73.17
UK
2,013
Diabetes
Respiratory
19.69
5.1
3.18
61+
Other
256,650
60.23
1.28
6.4
Therapy
45,491
Yes
70.02
4,475
3.32
68,721
0.62
41.16
South Korea
2,012
Rabies
Bacterial
12.7
13.73
9.57
36-60
Other
334,517
61.35
4.8
3.07
Surgery
16,126
Yes
56.76
2,234
2.02
7,505
0.55
59.21
Indonesia
2,017
Cancer
Chronic
4.31
1.93
1.47
36-60
Male
556,746
78.95
2.93
6.58
Surgery
20,591
Yes
61.49
1,234
7.57
42,413
0.59
31.63
Japan
2,024
Polio
Infectious
14.77
14.43
1.35
0-18
Male
667,317
67.93
4.29
9.34
Therapy
31,432
Yes
94.11
4,339
5.55
49,003
0.81
28.98
Japan
2,000
Zika
Bacterial
11.53
11.47
7.69
0-18
Other
290,756
91.98
3.44
5.03
Vaccination
40,724
Yes
95.75
164
4.92
21,179
0.59
85.16
UK
2,009
Zika
Cardiovascular
15.45
7.26
1.41
36-60
Male
854,602
89.66
4.78
6.94
Therapy
37,653
Yes
64.21
2,312
9.73
47,283
0.84
39.32
Nigeria
2,018
Cancer
Metabolic
11.44
0.81
5.38
36-60
Other
643,643
63.21
4.69
5.52
Medication
344
Yes
69.6
1,938
7.06
44,710
0.64
74.24
South Korea
2,013
Rabies
Genetic
19.06
2.51
2.43
61+
Male
58,475
67.98
1.98
2.87
Therapy
40,700
No
69.17
1,730
2.15
20,170
0.43
36.84
Turkey
2,002
Zika
Chronic
3.32
14.79
2.91
36-60
Other
564,523
61.28
0.51
7.01
Therapy
39,307
No
61.33
1,351
6.07
26,313
0.58
45.06
Russia
2,022
Parkinson's Disease
Cardiovascular
16.73
4.66
6.08
19-35
Other
156,478
68.75
4.16
1.87
Therapy
27,767
No
59.14
290
3.48
2,843
0.57
76.3
Germany
2,018
Hypertension
Autoimmune
9.07
6.52
8.42
0-18
Other
121,250
74.93
4.32
1.96
Medication
31,664
Yes
97.19
2,865
4.44
61,070
0.54
49.86
Australia
2,005
Hepatitis
Chronic
19.98
9.56
2.22
36-60
Male
53,022
52.1
0.83
2.6
Medication
3,935
No
97.96
3,024
8.72
58,715
0.66
83.66
India
2,005
Cancer
Infectious
18.86
2.25
4.38
36-60
Female
823,359
58.02
3.18
5.53
Surgery
15,174
No
59.73
4,503
0.78
36,443
0.49
29.2
South Africa
2,003
COVID-19
Neurological
16.01
4.38
2.86
61+
Other
35,305
71.48
3.88
5.96
Vaccination
23,426
Yes
62.2
65
2.83
44,887
0.6
48.27
India
2,020
Parkinson's Disease
Infectious
2.86
4.53
4.42
36-60
Other
357,831
96.55
4.9
2.22
Therapy
41,500
Yes
71.21
1,536
3.21
86,245
0.62
27.65
Argentina
2,007
Hypertension
Metabolic
8.73
0.64
5.62
36-60
Male
108,458
78.73
4.34
9.02
Therapy
12,545
Yes
73.98
3,511
1.25
30,850
0.56
85.38
Canada
2,010
Polio
Neurological
2.27
2.67
0.75
61+
Other
876,688
81.61
3.5
9.39
Surgery
34,589
No
59.12
1,058
5.66
43,052
0.83
40.88
Italy
2,011
Alzheimer's Disease
Neurological
14.07
10.43
4.45
36-60
Male
980,736
90.03
1.45
9.67
Medication
23,566
Yes
90.08
820
6.09
31,909
0.73
30.04
France
2,022
HIV/AIDS
Neurological
19.04
12.41
1.38
19-35
Male
74,729
75.66
4.99
8.6
Vaccination
16,887
No
60.5
3,376
8.24
6,042
0.62
59.84